A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ospemifene is more effective than placebo
in the treatment of vulvar and vaginal atrophy (VVA) in postmenopausal women.